Please login to the form below

Antiretroviral therapy

This page shows the latest Antiretroviral therapy news and features for those working in and with pharma, biotech and healthcare.

NHS England will make PrEP for HIV available in April

The PrEP Impact Trial is using Mylan's generic version of Gilead Sciences’ antiretroviral therapy Truvada (emtricitabine/tenofovir disoproxil) but is due to come to an end in October.

Latest news

Gilead drug reduces HIV viral reservoir, says researcher

suppression prior to starting antiretroviral therapy (ART). ... Stem cell transplants are high-risk procedures, so the treatment wouldn’t be suitable as a routine therapy for HIV-positive people.
FDA rejects ViiV’s long-acting monthly HIV injection

ATLAS involved pateints who had been previously treated with long-acting antiretroviral therapy (ART), and showed that the combination injection matched standard therapy on viral suppression rates. ... Three patients treated with ViiV’s injectable (1%)
Dovato approval key for Glaxo in HIV treatment

ViiV already have another two-in-one STR, Juluca (dolutegravir/rilpivirine), but this is only approved for HIV patients who have achieved viral suppression with another antiretroviral therapy. ... The HIV therapy market is also likely to be affected by
GSK, J&J say monthly injection keeps HIV controlled

The long-acting antiretroviral therapy (ART) could mean that more patients adhere to the treatment regimen needed to suppress HIV, and avoid the risk of skipped doses that can help viral ... If approved, this two-drug regimen would give people living
GSK’s says depot HIV injection works over three years

Moreover, patients in a control arm receiving standard oral antiretroviral therapy (ART) who elected to swap over to the injectable regimen after 96 weeks did so without loss of viral suppression, ... combinations GSK is hoping will simplify HIV therapy

More from news
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest Intelligence

Choices, choices: the rapidly evolving HIV treatment landscape

This type of combination therapy is known as highly active antiretroviral therapy (HAART), and remains the recommended treatment for HIV today. ... Ipsos' HIV Therapy Monitor data shows that the top reason for prescribing an STR is convenience.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

WHITE PAPER: Patient nonadherence – the $637bn paradox

low level of education. culture. lay beliefs. THERAPY-RELATED FACTORS. complexity of regimen. ... How well do. clinicians estimate patients’ adherence to combination antiretroviral therapy?
What about me? Human centricity rather than patient centricity…

While the advances in antiretroviral therapy (ART) have transformed the prognosis for a whole patient cohort, the role and sense of self of HIV specialists has undeniably changed, which in turn
Marketing strategy in complex environments

Whilst not new, this approach is becoming increasingly effective for certain therapy areas, particularly oncology. ... Another popular combination therapy is HAART: Highly Active Antiretroviral Therapy used for HIV where six major types of drugs

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Senior Account Manager: Competitive

Healthcare Account Director: Competitive

Healthcare Lead Copywriter: Competitive

Medical Editor: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Account Director – Creative Healthcare Communications: Competative

PMHub

Add my company

Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...